Financials
- Market Capitalization 922.5 M
- Employee 19
- Founded 2007
- CEO William H. Collier
- Website www.arbutusbio.com
- Headquarter British Columbia, Canada
- FIGI BBG000RR8V85
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2510 | DBVT DBV Technologies S.A. - American Depositary Shares | 15.98 USD | -3.09% | -0.44% | -9.62% | +53.21% | 946.15 M USD | ||
| 2524 | LBRX LB Pharmaceuticals Inc - Common Stock | 32.25 USD | -2.12% | -6.03% | +12.96% | +69.74% | 924.82 M USD | ||
| 2526 | ANNX Annexon, Inc. - common stock | 5.63 USD | -2.93% | -6.01% | +17.29% | +114.07% | 922.43 M USD | ||
| 2535 | GERN Geron Corporation - Common Stock | 1.42 USD | -5.33% | -1.39% | +22.41% | +6.77% | 910.96 M USD |
Frequently asked questions about Arbutus Biopharma Corporation - Common Stock
What is the Arbutus Biopharma Corporation - Common Stock stock price today?
The current price of Arbutus Biopharma Corporation - Common Stock (ABUS) is 4.67. Over the past 24 hours, the stock has changed by -2.71%. Follow the ABUS chart for real-time price dynamics.
What is the stock ticker of Arbutus Biopharma Corporation - Common Stock?
Arbutus Biopharma Corporation - Common Stock trades under the ticker ABUS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Arbutus Biopharma Corporation - Common Stock stock going up?
ABUS has changed by -6.22% over the last week, +8.60% over the last month, and +44.58% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Arbutus Biopharma Corporation - Common Stock net income for the last quarter?
Arbutus Biopharma Corporation - Common Stock reported net income of 169.69 M for the last quarter. The previous quarter showed -3.76 M, which means net income changed by +4617.97%.
How many employees does Arbutus Biopharma Corporation - Common Stock have?
As of the latest available data, Arbutus Biopharma Corporation - Common Stock has 19 employees. Workforce size can provide additional context about the company's scale and operations.
What is Arbutus Biopharma Corporation - Common Stock EBITDA?
Arbutus Biopharma Corporation - Common Stock EBITDA is 168.92 M, and its EBITDA margin is 94.3%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Arbutus Biopharma Corporation - Common Stock stock?
You can buy Arbutus Biopharma Corporation - Common Stock (ABUS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Arbutus Biopharma Corporation - Common Stock stock?
Investing in Arbutus Biopharma Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ABUS chart and related analysis on metatrader.com as part of your research.